An Australian local diagnostic reference level for paediatric whole-body


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 18 1 2019
medline: 9 4 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

The aim of this study is to report a local diagnostic reference level (DRL) for paediatric whole-body (WB) fludeoxyglucose ( The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) national DRL (NDRL) age category (0-4 years and 5-14 years), the International Commission on Radiological Protection age category (ICRP age) (<1, >1-5, >5-10, and >10-15 years), and European guideline weight category ( EG weight) (<5, 5-<15, 15-<30, 30-<50, and 50-<80 kg) were used to determine a local DRL for WB The local DRLs for The determined local DRL values for the radiation doses associated with WB The local DRL value determined from WB

Identifiants

pubmed: 30653334
doi: 10.1259/bjr.20180879
pmc: PMC6540867
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20180879

Références

Pediatr Radiol. 2010 May;40(5):681-6
pubmed: 19967534
J Nucl Med. 2011 Feb;52(2):318-22
pubmed: 21233182
Br J Radiol. 2012 Nov;85(1019):1488-98
pubmed: 22844033
Radiat Prot Dosimetry. 2013 Apr;154(1):52-75
pubmed: 22956562
Eur J Nucl Med Mol Imaging. 2014 May;41(5):1036-41
pubmed: 24599377
Pediatr Radiol. 2015 Apr;45(5):706-13
pubmed: 25367355
Ann ICRP. 2015 Jul;44(2 Suppl):7-321
pubmed: 26069086
J Radiol Prot. 2015 Dec;35(4):891-909
pubmed: 26609995
Medicine (Baltimore). 2015 Dec;94(50):e2146
pubmed: 26683922
J Korean Med Sci. 2016 Feb;31 Suppl 1:S69-74
pubmed: 26908992
Australas Phys Eng Sci Med. 2016 Sep;39(3):615-26
pubmed: 27350262
J Nucl Med. 2016 Dec;57(12):15N-18N
pubmed: 27909182
Semin Nucl Med. 2017 Mar;47(2):118-125
pubmed: 28237000
J Nucl Med. 2017 Sep;58(9):1360-1366
pubmed: 28687601
Ann ICRP. 2017 Oct;46(1):1-144
pubmed: 29065694
Radiat Prot Dosimetry. 2018 Dec 1;182(4):532-545
pubmed: 30137488
Clin Nucl Med. 1983 Sep;8(9):434-9
pubmed: 6641077

Auteurs

Essam Mohammed Alkhybari (EM)

1 Faculty of Health Sciences, Discipline of Medical Radiation Science, The University of Sydney , Sydney, NSW , Australia.
2 Faculty of Applied Medical Sciences, Department of Radiology and Medical Imaging, Prince Sattam Bin Abdulaziz University , Al kharj , Saudi Arabia.

Mark F McEntee (MF)

1 Faculty of Health Sciences, Discipline of Medical Radiation Science, The University of Sydney , Sydney, NSW , Australia.

Kathy P Willowson (KP)

3 Institute of Medical Physics, The University of Sydney , Sydney, New South Wales , Australia.

Patrick C Brennan (PC)

1 Faculty of Health Sciences, Discipline of Medical Radiation Science, The University of Sydney , Sydney, NSW , Australia.

Theo Kitsos (T)

4 Department of Nuclear Medicine, The Children's Hospital at Westmead , Sydney, NSW , Australia.

Peter L Kench (PL)

1 Faculty of Health Sciences, Discipline of Medical Radiation Science, The University of Sydney , Sydney, NSW , Australia.
5 Brain and Mind Research Institute, The University of Sydney , Sydney, NSW , Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH